Clinical Impact of Residual C-Peptide Secretion in Type 1 Diabetes on Glycemia and Microvascular Complications

To quantify the relationship of residual C-peptide secretion to glycemic outcomes and microvascular complications in type 1 diabetes. C-peptide was measured in an untimed blood sample in the Scottish Diabetes Research Network Type 1 Bioresource (SDRNT1BIO) cohort of 6,076 people with type 1 diabetes...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Diabetes care 2021-02, Vol.44 (2), p.390-398
Hauptverfasser:	Jeyam, Anita, Colhoun, Helen, McGurnaghan, Stuart, Blackbourn, Luke, McDonald, Timothy J, Palmer, Colin N A, McKnight, John A, Strachan, Mark W J, Patrick, Alan W, Chalmers, John, Lindsay, Robert S, Petrie, John R, Thekkepat, Sandeep, Collier, Andrew, MacRury, Sandra, McKeigue, Paul M
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood glucose Clinical trials Complications Diabetes Diabetes mellitus Diabetes mellitus (insulin dependent) Diabetic ketoacidosis Hypoglycemia Insulin Ketoacidosis Microvasculature Pancreas Peptides Recovery of function Regression analysis Regression models Research design Retinopathy Secretion
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!